Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors
Condition(s):Prostate-specific Membrane Antigen; mCRPC or Advanced/Metastatic Solid TumorsLast Updated:June 1, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Prostate-specific Membrane Antigen; mCRPC or Advanced/Metastatic Solid TumorsLast Updated:June 1, 2023Recruiting
Condition(s):Prostate Adenocarcinoma; MetastasisLast Updated:May 10, 2019Completed
Condition(s):Bone Cancer; Bone Tumor; Solid Tumor; Metastatic Cancer to the Bone; Metastatic Tumor to the BoneLast Updated:August 23, 2023Recruiting
Condition(s):Prostate CancerLast Updated:December 24, 2007Completed
Condition(s):Prostate CancerLast Updated:April 4, 2023Completed
Condition(s):Hormone Refractory Prostate CancerLast Updated:January 21, 2009Unknown status
Condition(s):Anemia; Metastatic Cancer; Myelodysplastic Syndromes; Precancerous Condition; Prostate CancerLast Updated:February 11, 2014Completed
Condition(s):Metastatic Castration-resistant Prostate Cancer; Recurrent Epithelial Ovarian Cancer; Breast CancerLast Updated:March 31, 2023Recruiting
Condition(s):Castrate Resistant Prostate Cancer With Bone MetastasisLast Updated:February 28, 2024Withdrawn
Condition(s):Prostate CancerLast Updated:October 29, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.